Oral immunoadjuvant activity of Lactobacillus casei subsp. casei in dextran-fed layer chickens

British Journal of Nutrition

Volumn 95, Issue 2, 2006, Pages 430-434

  Ogawa, Tomohikp ^a   Asai, Yasuyuki ^a   Sakamoto, Hiromi ^a   Yasuda, Kenji ^a  

^a ASAHI UNIVERSITY   (Japan)

Author keywords

Chicken; Dextran; Lactobacillus casei; Synbiotic

Indexed keywords

BOVINE SERUM ALBUMIN; DEXTRAN; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; NEW BRONZ MG; NEWCASTLE DISEASE VACCINE; PREBIOTIC AGENT; VIRUS VACCINE; INACTIVATED VACCINE; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; AVIAN INFECTIOUS BRONCHITIS VIRUS; AVIAN INFLUENZA; BACTERIAL STRAIN; BACTERIUM DETECTION; BIRD DISEASE; CHICKEN; COLONY FORMING UNIT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG SYNTHESIS; GASTROINTESTINAL TRACT; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; LACTOBACILLUS CASEI; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ANIMAL; ANIMAL FOOD; BIOSYNTHESIS; IMMUNOLOGY; INTESTINE; INTRADERMAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEWCASTLE DISEASE PARAMYXOVIRUS; ORAL DRUG ADMINISTRATION; VIRUS INFECTION;

ANIMALIA; AVES; AVIAN INFECTIOUS BRONCHITIS VIRUS; BACTERIA (MICROORGANISMS); BOVINAE; GALLUS GALLUS; LACTOBACILLUS CASEI;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ANIMAL FEED; ANIMALS; CHICKENS; CORONAVIRUS INFECTIONS; DEXTRANS; IMMUNOGLOBULIN G; INFECTIOUS BRONCHITIS VIRUS; INTESTINES; LACTOBACILLUS CASEI; MALE; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; PROBIOTICS; VACCINES, INACTIVATED;

EID: 33644895714     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1079/BJN20051629     Document Type: Article

References (31)

1. Agriculture, Forestry and Fisheries Research Council Secretariat (1999) Japanese Feeding Standard for Poultry. Tokyo, Japan: Agriculture, Forestry and Fisheries Research Council.
2. Ahrne S, Nobaek S, Jeppsson B, Adlerberth I, Wold AE & Molin G (1998) The normal Lactobacillus flora of healthy human rectal and oral mucosa. J Appl Microbiol 85, 88-94.
3. Alexander DJ (1997) Newcastle disease and other avian Paramyxoviridae infection. In Disease of Poultry, 10th ed., pp. 541-570 [BW Calnek, JH Barnes, CW Beard, LR McDougald and YM Saif, editors]. Ames, IA: Iowa State University Press.
4. Bailey JS, Blankenship LC & Cox NA (1991) Effect of fructooligosaccharide on salmonella colonization of the chicken intestine. Poult Sci 70, 2433-2438.
5. Cavanagh D & Naqi SA (1997) Infectious bronchitis. In Disease of Poultry, 10th ed., pp. 511-526 [BW Calnek, JH Barnes, CW Beard, LR McDougald and YM Saif, editors]. Ames, IA: Iowa State University Press.
6. Erickson KL & Hubbard NE (2000) Probiotic immunomodulation in health and disease. J Nutr 130, Suppl., 403S-409S.
7. Freter R (1956) Experimental enteric Shigella and Vibrio infections in mice and guinea pigs. J Exp Med 104, 411-418.
8. Fuller R (1989) Probiotics in man and animals. J Appl Bacteriol 66, 365-378.
9. Gibson GR & Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125, 1401-1412.
10. Gibson GR & Wang X (1994) Bifidogenic properties of different types of fructo-oligosaccharides. Food Microbiol 11, 491-498.
11. Gusils C, Gonzalez SN & Oliver G (1999) Some probiotic properties of chicken lactobacilli. Can J Microbiol 45, 981-987.
12. Haller D, Bode C, Hammes WP, Pfeifer AMA, Schiffrin EJ & Blum S (2000) Non-pathogenic bacteria elicit a differential cytokine responses by intestinal epithelial cell/leukocyte co-cultures. Gut 47, 79-87.
13. Koenen ME, Heres L, Claassen E & Boeresma WJA (2002) Lactobacilli as probiotics in chickens feeds. Biosci Microflora 21, 209-216.
14. MacGillivray PC, Finlay HVL & Binns TB (1959) Use of lactulose to create a preponderance of lactobacilli in the intestine of bottle-fed infants. Scott Med J 4, 182-189.
15. Matsuzaki T & Chin J (2000) Modulating immune responses with probiotic bacteria. Immunol Cell Biol 78, 67-73.
16. Matsuzaki T, Yokokura T & Mutai M (1988) Antitumor effect of intrapleural administration of Lactobacillus casei in mice. Cancer Immunol Immunother 26, 209-214.
17. Miller C (1959) Protective action of the normal microflora against enteric infection: an experimental study in the mouse. Univ Minn Med Bull 25, 272-279.
18. Ogawa T, Asai Y, Yasuda K & Sakamoto H (2005) Oral immunoadjuvant activity of a new synbiotic, Lactobacillus casei subsp. casei in conjunction with dextran in BALB/c mice. Nutr Res 25, 295-304.
19. Ogawa T, Kotani S & Shimauchi H (1986) Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin. Methods Find Exp Clin Pharmacol 8, 117-125.
20. Ogawa T, Kusumoto Y, Kiyono H, McGhee JR & Hamada S (1992) Occurrence of antigen-specific B cells following oral or parenteral immunization with Porphyromonas gingivalis fimbriae. Int Immunol 4, 1003-1010.
21. Ogawa T, Shimauchi H, Furuta R, Kawata S, Yokogawa K & Kotani S (1995) Oral immunoadjuvant activity of lipophilic derivatives of N-acetyl-glucosaminyl-β (1 → 4)-N-acetylmuramily-L-alanyl-D-isoglutaminyl-(L)-meso-2,6-diaminopimelic acid-(D)-amide. Vaccine 13, 887-889.
22. Ouwehand AC, Salminen S & Isolauri E (2002) Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 82, 279-289.
23. Perdigón G, de Macias ME, Alvarez S, Oliver G & de Ruiz Holgado AA (1986) Effect of perorally administered lactobacilli on macrophage activation in mice. Infect Immun 53, 404-410.
24. Rolfe RD (2000) The role of probiotics cultures in the control of gastrointestinal health. J Nutr 130, Suppl., 396S-402S.
25. Rowland IR & Tanaka R (1993) The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human faecal microflora. J Appl Bacteriol 74, 667-674.
26. Sun M (1984) Use of antibiotics in animal feed challenged. Science 226, 144-146.
27. Takagi A, Matsuzaki T, Sato M, Nomoto K, Morotomi M & Yokokura T (2001) Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism. Carcinogenesis 22, 599-605.
28. van Den Bogaard AE, Bruinsma N & Stobberingh EE (2000) The effect of banning avoparcin on VRE carriage in the Netherlands. J Antimicrob Chemother 46, 145-153.
29. Villegas P (1998) Viral diseases of the respiratory system. Poult Sci 77, 1143-1145.
30. Wang C-H, Hong C-C & Seak JCH (2002) An ELISA for antibodies against infectious bronchitis virus using an S1 spike polypeptide. Vet Microbiol 85, 333-342.
31. World Health Organization (2003) Impacts of Antimicrobial Growth Promoter Termination in Denmark. Geneva: WHO.